← Search

Ola Engkvist

4 accepted papers

2026

FlexiFlow: decomposable flow matching for generation of flexible molecular ensemble

ICML 2026poster

Sampling useful three-dimensional molecular structures along with their most favorable conformations is a key challenge in drug discovery. Current state-of-the-art 3D de-novo design flow matching or diffusion-based models are limited to generating a single conformation. However, the conformational l…

Cited by 0Source ↗Scholar ↗
2025

Boltzmann priors for Implicit Transfer Operators

ICLR 2025poster

Accurate prediction of thermodynamic properties is essential in drug discovery and materials science. Molecular dynamics (MD) simulations provide a principled approach to this task, yet they typically rely on prohibitively long sequential simulations. Implicit Transfer Operator (ITO) Learning offers…

2025

Diversity-Aware Reinforcement Learning for de novo Drug Design

IJCAI 2025

Fine-tuning a pre-trained generative model has demonstrated good performance in generating promising drug molecules. The fine-tuning task is often formulated as a reinforcement learning problem, where previous methods efficiently learn to optimize a reward function to generate potential drug molecul

Cited by 0Source ↗PDF ↗Scholar ↗
2023

Industry-Scale Orchestrated Federated Learning for Drug Discovery

AAAI 2023technical

To apply federated learning to drug discovery we developed a novel platform in the context of European Innovative Medicines Initiative (IMI) project MELLODDY (grant n°831472), which was comprised of 10 pharmaceutical companies, academic research labs, large industrial companies and startups. The MEL…

Cited by 48Source ↗PDF ↗Scholar ↗